Heterogeneity in susceptibility to hydroxychloroquine of SARS-CoV-2 isolates

Heterogeneity in susceptibility to hydroxychloroquine of SARS-CoV-2 isolates

Background: Despite the fact that the clinical efficacy of hydroxychloroquine is still controversial, it has been demonstrated in vitro to control SARS-CoV-2 multiplication on Vero E6 cells. In this study, we tested the possibility that some patients with prolonged virus excretion could be infected...

Full description

Bibliographic Details
Main Authors: Celine Boschi, Marion Le Bideau, Julien Andreani, Sarah Aherfi, Priscilla Jardot, Jeremy Delerce, Mathieu Gendrot, Bruno Pradines, Philippe Colson, Anthony Levasseur, Bernard La Scola
Format: Article
Language:English
Published: IMR Press 2021-12-01
Series:Frontiers in Bioscience-Landmark
Subjects:
sars-cov-2
hydroxychloroquine
azithromycin
in vitro model
vero e6
wgs
africa
Online Access:https://www.imrpress.com/journal/FBL/26/12/10.52586/5043

Similar Items

Similar Items